Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
Med Clin (Barc). 2022 Nov 11;159(9):453-454.
doi: 10.1016/j.medcli.2022.07.017.
Epub 2022 Aug 11.
[Article in
English,
Spanish]
Affiliations
- 1 Hospital Sociosanitario Francolí, Tarragona, España. Electronic address: essopena.gipss@gencat.cat.
- 2 Hospital Sociosanitario Francolí, Tarragona, España.
No abstract available
MeSH terms
-
COVID-19* / complications
-
Diarrhea / drug therapy
-
Diarrhea / etiology
-
Helicobacter Infections*
-
Humans
-
SARS-CoV-2
Substances
-
bismuth tripotassium dicitrate